Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Mirabegron> ?p ?o. }
Showing items 1 to 60 of
60
with 100 items per page.
- Mirabegron abstract "Mirabegron (formerly YM-178, trade name Myrbetriq) is a drug for the treatment of overactive bladder. It was developed by Astellas Pharma and was approved in the United States in July 2012.Mirabegron activates the β3 adrenergic receptor in the detrusor muscle in the bladder, which leads to muscle relaxation and an increase in bladder capacity.".
- Mirabegron atcPrefix "G04".
- Mirabegron atcSuffix "BD12".
- Mirabegron bioavailability "29.0".
- Mirabegron casNumber "223673-61-8".
- Mirabegron iupacName "2-(2-Amino-1,3-thiazol-4-yl)-N-[4-(2-{[(2R)-2-hydroxy-2-phenylethyl]amino}ethyl)phenyl]acetamide".
- Mirabegron pubchem "9865528".
- Mirabegron thumbnail Mirabegron2DACS2.svg?width=300.
- Mirabegron wikiPageID "37152764".
- Mirabegron wikiPageRevisionID "587848372".
- Mirabegron atcPrefix "G04".
- Mirabegron atcSuffix "BD12".
- Mirabegron bioavailability "29".
- Mirabegron c "21".
- Mirabegron casNumber "223673".
- Mirabegron chemspiderid "8041219".
- Mirabegron drugName "Mirabegron".
- Mirabegron eliminationHalfLife "180000.0".
- Mirabegron excretion "Urine , faeces".
- Mirabegron h "24".
- Mirabegron hasPhotoCollection Mirabegron.
- Mirabegron inchi "1".
- Mirabegron inchikey "PBAPPPCECJKMCM-IBGZPJMEBA".
- Mirabegron iupacName "2".
- Mirabegron legalUk "POM".
- Mirabegron legalUs "Rx-only".
- Mirabegron licenceEu "Betmiga".
- Mirabegron licenceUs "Mirabegron".
- Mirabegron metabolism "Hepatic via glucuronidation, amide hydrolysis, and minimal oxidative metabolism in vivo by CYP2D6 and CYP3A4. Some involvement of butylcholinesterase".
- Mirabegron molecularWeight "396.506".
- Mirabegron n "4".
- Mirabegron o "2".
- Mirabegron pregnancyUs "C".
- Mirabegron proteinBound "71.0".
- Mirabegron pubchem "9865528".
- Mirabegron routesOfAdministration "Oral".
- Mirabegron s "1".
- Mirabegron smiles "O=CCc3ncN".
- Mirabegron stdinchi "1".
- Mirabegron stdinchikey "PBAPPPCECJKMCM-IBGZPJMESA-N".
- Mirabegron synonyms "YM-178".
- Mirabegron tradename "Myrbetriq , Betanis , Betmiga".
- Mirabegron width "250".
- Mirabegron subject Category:Beta-adrenergic_agonists.
- Mirabegron subject Category:Thiazoles.
- Mirabegron type Drug.
- Mirabegron type FunctionalSubstance.
- Mirabegron comment "Mirabegron (formerly YM-178, trade name Myrbetriq) is a drug for the treatment of overactive bladder. It was developed by Astellas Pharma and was approved in the United States in July 2012.Mirabegron activates the β3 adrenergic receptor in the detrusor muscle in the bladder, which leads to muscle relaxation and an increase in bladder capacity.".
- Mirabegron label "Mirabegron".
- Mirabegron label "Mirabegron".
- Mirabegron label "Mirabegron".
- Mirabegron sameAs Mirabegron.
- Mirabegron sameAs Mirabegron.
- Mirabegron sameAs m.0n47qgr.
- Mirabegron sameAs Q3702534.
- Mirabegron sameAs Q3702534.
- Mirabegron wasDerivedFrom Mirabegron?oldid=587848372.
- Mirabegron depiction Mirabegron2DACS2.svg.
- Mirabegron isPrimaryTopicOf Mirabegron.
- Mirabegron name "Mirabegron".